Nutrition, microbiome and multiple sclerosis. Current knowledge from basic research and clinical practice

被引:0
|
作者
Haghikia, A. [1 ]
Linker, R. A. [2 ]
机构
[1] Ruhr Univ Bochum, St Josef Hosp, Neurol Klin, Gudrunstr 56, D-44971 Bochum, Germany
[2] Univ Klinikum Erlangen, Neurol Klin, Schwabachanlage 6, D-91054 Erlangen, Germany
来源
NERVENARZT | 2018年 / 89卷 / 04期
关键词
Pathogenesis; Salt; Fatty acid; Smoking; Alcohol; ENVIRONMENTAL RISK-FACTORS; DIETARY-SODIUM INTAKE; BODY-MASS INDEX; FATTY-ACIDS; AUTOIMMUNE-DISEASE; GUT MICROBIOTA; CELLS; MS; DEMYELINATION; METABOLITES;
D O I
10.1007/s00115-018-0497-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epidemiological data indicate a disproportional increase in the incidence of multiple sclerosis (MS) over the last decades, particularly in industrialized countries. Although this increase is also associated with altered diagnostic criteria and improved sensitivity of imaging procedures, current data suggest that particularly alterations in our way of life play an important role. In recent years the importance of the gut and intestinal microbiome for some neurological diseases and in particular for MS was recognized. Because nutritional habits have a substantial influence on the composition of the microbiome and our nutrition has changed considerably in the last decades, nutritional components can play an important role in the pathogenesis of MS. In this further education article we summarize the currently available evidence on the role of the gut and on the effects of dietary components on the microbiome in the pathogenesis of MS.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 50 条
  • [21] Immunoreactivity to axonal proteins in multiple sclerosis. A survey from clinical to biological markers
    Maria de los Angeles, Robinson-Agramonte
    Jose Antonio, Cabrera Gomez
    Reiber, Hansotto
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 174 - 174
  • [22] Targeting B cells in multiple sclerosis. Current concepts and strategies
    Menge, T.
    Buedingen, H.-C.
    Dalakas, M. C.
    Kieseier, B. C.
    Hartung, H. -P.
    NERVENARZT, 2009, 80 (02): : 190 - 198
  • [23] Current concepts on the use of immunomodulatory drugs in the treatment of multiple sclerosis.
    Correale, J
    Cristiano, E
    MEDICINA-BUENOS AIRES, 2001, 61 (04) : 470 - 480
  • [24] Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research
    Grzegorski, Tomasz
    Losy, Jacek
    REVIEWS IN THE NEUROSCIENCES, 2017, 28 (08) : 845 - 860
  • [25] From neurofilament research to multiple sclerosis clinical practice Where do we stand?
    Bodini, Benedetta
    Calabresi, Peter Arthur
    NEUROLOGY, 2017, 88 (09) : 816 - 817
  • [26] CURRENT KNOWLEDGE OF MULTIPLE-SCLEROSIS
    JOHNSON, RT
    SOUTHERN MEDICAL JOURNAL, 1978, 71 (01) : 2 - 4
  • [27] Basic research and clinical practice
    Halac, Eduardo
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2011, 109 (04): : 383 - 383
  • [28] Remyelination in multiple sclerosis: from basic science to clinical translation
    Lubetzki, Catherine
    Zalc, Bernard
    Williams, Anna
    Stadelmann, Christine
    Stankoff, Bruno
    LANCET NEUROLOGY, 2020, 19 (08): : 678 - 688
  • [29] Diabetic dyslipidaemia: from basic research to clinical practice
    Taskinen, MR
    DIABETOLOGIA, 2003, 46 (06) : 733 - 749
  • [30] Silybin and the liver: From basic research to clinical practice
    Carmela Loguercio
    Davide Festi
    World Journal of Gastroenterology, 2011, 17 (18) : 2288 - 2301